| 1 |
34762160 | EZHIP: a new piece of the puzzle towards understanding pediatric posterior fossa ependymoma. | 2022 Jan |
1 |
| 2 |
34843930 | Role of EZH2 in bone marrow mesenchymal stem cells and immune-cancer interactions. | 2022 Jan |
2 |
| 3 |
34851506 | Ezh2 promotes TRβ lysine methylation-mediated degradation in hepatocellular carcinoma. | 2022 Mar |
7 |
| 4 |
34915417 | Non-coding RNAs-EZH2 regulatory mechanisms in cervical cancer: The current state of knowledge. | 2022 Feb |
2 |
| 5 |
35169119 | Induction of senescence-associated secretory phenotype underlies the therapeutic efficacy of PRC2 inhibition in cancer. | 2022 Feb 15 |
1 |
| 6 |
35256668 | Link between the EZH2 noncanonical pathway and microtubule organization center polarization during early T lymphopoiesis. | 2022 Mar 7 |
1 |
| 7 |
35478054 | Unique combinations of epigenetic modifiers synergistically impair the viability of the U87 glioblastoma cell line while exhibiting minor or moderate effects on normal stem cell growth. | 2022 Apr 28 |
1 |
| 8 |
35531606 | Targeting Enhancer of Zeste Homolog 2 for the Treatment of Hematological Malignancies and Solid Tumors: Candidate Structure-Activity Relationships Insights and Evolution Prospects. | 2022 May 26 |
2 |
| 9 |
35569264 | Targeting EZH2 for cancer therapy: From current progress to novel strategies. | 2022 Aug 5 |
1 |
| 10 |
35574370 | lncRNA PRADX is a Mesenchymal Glioblastoma Biomarker for Cellular Metabolism Targeted Therapy. | 2022 |
1 |
| 11 |
35574589 | Complex cross-talk between EZH2 and miRNAs confers hallmark characteristics and shapes the tumor microenvironment. | 2022 Jun |
1 |
| 12 |
35609316 | EZH2 enhances proliferation and migration of trophoblast cell lines by blocking GADD45A-mediated p38/MAPK signaling pathway. | 2022 May |
1 |
| 13 |
35610640 | Role of EZH2-mediated H3K27me3 in placental ADAM12-S expression: implications for fetoplacental growth. | 2022 May 25 |
2 |
| 14 |
32820394 | LINC01436 Inhibited miR-585-3p Expression and Upregulated MAPK1 Expression to Promote Gastric Cancer Progression. | 2021 Jun |
1 |
| 15 |
33063698 | Structural assembly of Polycomb group protein and Insight of EZH2 in cancer progression: A review. | 2021 Apr-Jun |
1 |
| 16 |
33122827 | Epigenetic silencing of LncRNA LINC00261 promotes c-myc-mediated aerobic glycolysis by regulating miR-222-3p/HIPK2/ERK axis and sequestering IGF2BP1. | 2021 Jan |
1 |
| 17 |
33436557 | Dual EZH2 and G9a inhibition suppresses multiple myeloma cell proliferation by regulating the interferon signal and IRF4-MYC axis. | 2021 Jan 12 |
1 |
| 18 |
33556366 | Noncanonical Functions of the Polycomb Group Protein EZH2 in Breast Cancer. | 2021 May |
1 |
| 19 |
33614242 | Epigenetically modulated miR-1224 suppresses the proliferation of HCC through CREB-mediated activation of YAP signaling pathway. | 2021 Mar 5 |
1 |
| 20 |
33615636 | The noncanonical role of EZH2 in cancer. | 2021 Apr |
1 |
| 21 |
33679454 | Histone Methyltransferase EZH2: A Potential Therapeutic Target for Kidney Diseases. | 2021 |
2 |
| 22 |
33800594 | Peritoneal Modulators of EZH2-miR-155 Cross-Talk in Endometriosis. | 2021 Mar 28 |
1 |
| 23 |
33827814 | Posttranslational regulation of FOXA1 by Polycomb and BUB3/USP7 deubiquitin complex in prostate cancer. | 2021 Apr |
2 |
| 24 |
33978549 | Targeting EZH2-mediated methylation of histone 3 inhibits proliferation of pediatric acute monocytic leukemia cells in vitro. | 2021 Apr 3 |
3 |
| 25 |
33986254 | Targeting epigenetic modulation of cholesterol synthesis as a therapeutic strategy for head and neck squamous cell carcinoma. | 2021 May 13 |
1 |
| 26 |
34029268 | EZH2 as an Epigenetic Regulator of Cardiovascular Development and Diseases. | 2021 Aug 1 |
2 |
| 27 |
34065631 | Disruption of YY1-EZH2 Interaction Using Synthetic Peptides Inhibits Breast Cancer Development. | 2021 May 16 |
2 |
| 28 |
34094676 | HMGA1 induces EZH2 overexpression in human B-cell lymphomas. | 2021 |
1 |
| 29 |
34105888 | LncRNA LINC00525 suppresses p21 expression via mRNA decay and triplex-mediated changes in chromatin structure in lung adenocarcinoma. | 2021 Jul |
2 |
| 30 |
34230470 | EZH2-induced lysine K362 methylation enhances TMPRSS2-ERG oncogenic activity in prostate cancer. | 2021 Jul 6 |
2 |
| 31 |
34358125 | Development of Machine Learning Models for Accurately Predicting and Ranking the Activity of Lead Molecules to Inhibit PRC2 Dependent Cancer. | 2021 Jul 20 |
2 |
| 32 |
34372908 | PRC2: an epigenetic multiprotein complex with a key role in the development of rhabdomyosarcoma carcinogenesis. | 2021 Aug 9 |
1 |
| 33 |
34376807 | EZH2 expression is associated with inferior overall survival in mantle cell lymphoma. | 2021 Dec |
2 |
| 34 |
34401209 | lncRNA H19 facilitates the proliferation and differentiation of human dental pulp stem cells via EZH2-dependent LATS1 methylation. | 2021 Sep 3 |
1 |
| 35 |
34493753 | Reciprocal regulation of endothelial-mesenchymal transition by MAPK7 and EZH2 in intimal hyperplasia and coronary artery disease. | 2021 Sep 7 |
1 |
| 36 |
34512145 | Emerging Roles of LncRNAs in the EZH2-regulated Oncogenic Network. | 2021 |
2 |
| 37 |
34517264 | Combination of curcumin with N-n-butyl haloperidol iodide inhibits hepatocellular carcinoma malignant proliferation by downregulating enhancer of zeste homolog 2 (EZH2) - lncRNA H19 to silence Wnt/β-catenin signaling. | 2021 Oct |
1 |
| 38 |
34545456 | Long non-coding RNA FOXP4-AS1 facilitates the biological functions of hepatocellular carcinoma cells via downregulating ZC3H12D by mediating H3K27me3 through recruitment of EZH2. | 2021 Sep 21 |
2 |
| 39 |
34664960 | Discovery of IHMT-EZH2-115 as a Potent and Selective Enhancer of Zeste Homolog 2 (EZH2) Inhibitor for the Treatment of B-Cell Lymphomas. | 2021 Oct 28 |
2 |
| 40 |
34725436 | EZH1/2 inhibition augments the anti-tumor effects of sorafenib in hepatocellular carcinoma. | 2021 Nov 1 |
1 |
| 41 |
34737746 | Easy or Not-The Advances of EZH2 in Regulating T Cell Development, Differentiation, and Activation in Antitumor Immunity. | 2021 |
2 |
| 42 |
34737956 | Novel Natural Inhibitors Targeting Enhancer of Zeste Homolog 2: A Comprehensive Structural Biology Research. | 2021 |
2 |
| 43 |
34764950 | Single-Cell Sequencing Reveals the Novel Role of Ezh2 in NK Cell Maturation and Function. | 2021 |
2 |
| 44 |
34771469 | TPH1 and 5-HT7 Receptor Overexpression Leading to Gemcitabine-Resistance Requires Non-Canonical Permissive Action of EZH2 in Pancreatic Ductal Adenocarcinoma. | 2021 Oct 22 |
1 |
| 45 |
34806925 | LncRNA SNHG1 promotes tumor progression and cisplatin resistance through epigenetically silencing miR-381 in breast cancer. | 2021 Dec |
3 |
| 46 |
34825659 | Functional relationship of SNP (Ala490Thr) of an epigenetic gene EZH2 results in the progression and poor survival of ER+/tamoxifen treated breast cancer patients. | 2021 |
1 |
| 47 |
31636385 | HNF1B-mediated repression of SLUG is suppressed by EZH2 in aggressive prostate cancer. | 2020 Feb |
2 |
| 48 |
32322039 | Mutational mechanisms of EZH2 inactivation in myeloid neoplasms. | 2020 Dec |
1 |
| 49 |
32378752 | Long noncoding RNA ANRIL promotes the malignant progression of cholangiocarcinoma by epigenetically repressing ERRFI1 expression. | 2020 Jul |
2 |
| 50 |
32394628 | Identification of catalytic and non-catalytic activity inhibitors against PRC2-EZH2 complex through multiple high-throughput screening campaigns. | 2020 Oct |
2 |